Interleukin-6 May Reliably Identify Patients with High-Grade Serous Ovarian Cancer
A new tool, in combination with those already existing, could distinguish between patients with malignant and benign ovarian masses, as well as those with a benign ovarian mass and normal ovaries.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Hannah Slater Source Type: news